GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.0124 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.2272 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, RELA, SMAD3, SRC, TEK, XDH |
12.2272 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, RELA, SMAD3, SRC, TEK, XDH |
12.2272 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD3, EGFR, ESR1, F2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MAOA, MET, MTNR1B, PPARA, SMAD3, SRC, TEK, XDH |
12.1214 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1B, NUAK1, RELA, SMAD3, SRC, TEK, XDH |
11.1965 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1B, NUAK1, RELA, SMAD3, SRC, TEK, XDH |
11.0342 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, EGFR, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MAP2K1, MAP3K7, MET, RELA, SRC, TEK, XDH |
10.9938 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, INSR, PPARA, PTGES, RELA, SRC, TEK, TYR |
10.9682 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CA2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TYR |
10.9049 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, ESR1, ESRRA, F2, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MMP12, NUAK1, PIM1, PTGES, RELA, SMAD3, SRC, TEK, XDH |
10.8771 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CA2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TYR |
10.4878 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, RELA, SRC, TEK, XDH |
10.4801 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, RELA, SMAD3, SRC, TEK, XDH |
10.1449 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, APP, AR, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FLT3, PTGES, RELA, SRC, TEK, TYR |
10.0621 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, AOX1, APP, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, GLO1, HSD17B3, HSPA1A, HTR2B, HTR2C, PIM1, PPARA, PTGES, TYR, XDH |
9.60354 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MAP2K1, MET, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
9.33651 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MAP2K1, MET, PIM1, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
9.33651 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, PPARA, RELA, SMAD3, SRC, TEK, TYR |
9.33648 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, PTGES, RELA, SRC, TYR |
9.22315 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, HCAR2, HSD17B1, HSD17B2, HSD17B3, HTR2A, HTR2C, MTNR1B |
8.89952 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD3, EGFR, ESR1, F2, FABP3, FABP4, FLT3, GPR35, HTR2A, HTR2B, HTR2C, INSR, MET, MTNR1B, SMAD3, SRC |
8.88997 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
8.74497 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MAP2K1, PIM1, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
8.72369 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD3, EGFR, ESRRA, F2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, RELA, SMAD3, SRC, TEK, XDH |
8.58037 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, F2, F3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, MTNR1B, PPARA, SMAD3, SRC, TEK |
8.46001 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, PPARA, RELA, SRC, TEK |
8.1009 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD3, EGFR, ESR1, F2, FABP3, FABP4, GPR35, HTR2A, HTR2B, HTR2C, INSR, MET, MTNR1B, SMAD3 |
8.03245 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, IGF1R, INSR, PPARA, RELA, SMAD3, SRC, TEK |
7.70692 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, DRD3, F2, HTR2A, HTR2B, HTR2C, KDR, SRC |
7.61225 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, F2, F3, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP12, NUAK1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A, TYR |
7.61225 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, CNR1, DRD3, EGFR, F2, HCAR2, HTR2A, HTR2B, HTR2C, KDR, SRC |
7.45599 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA3, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD3, EGFR, FABP3, HTR2A, HTR2B, HTR2C, KDR, RELA, SRC |
7.36311 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
7.25888 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD3, EGFR, ESRRB, F2, F3, HCAR2, HSPA1A, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MET, MMP12, PIM1, RELA, SMAD3, SRC, TEK |
7.0979 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GLO1, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MAP2K1, MET, MMP12, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
7.03546 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
7.03546 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, DRD3, F2, FABP3, FLT3, HCAR2, HTR2A, HTR2B, HTR2C, PPARA, SRC, TEK |
7.03546 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
7.00891 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CACNA1C, CNR1, CYP1B1, DRD3, EGFR, ESR1, ESRRA, ESRRB, F2, F3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, PIM1, RELA, SMAD3, SRC, TEK, XDH |
6.89788 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PPARA, RELA, SMAD3, SRC, TEK, XDH |
6.87967 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC, TEK |
6.78944 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, AR, BCL2, DRD3, DUSP3, EGFR, ESRRB, F2, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MTNR1A, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
6.73428 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, PTGES, RELA, SRC |
6.72698 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, RELA, SMAD3, SRC, TEK, XDH |
6.69487 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2, HSD17B3 |
6.69487 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, AR, BCL2, DRD3, DUSP3, EGFR, ESRRB, F2, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MTNR1A, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
6.6858 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CNR1, CNR2, CYP1A1, CYP1B1, DRD3, KDR, RELA, SRC |
6.54148 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, RELA, SMAD3, SRC, TEK |
6.46171 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, FUT7, GLO1, HSD17B2, HSD17B3, HTR2A, HTR2B, INSR, KDR, MAP2K1, MET, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, TYR |
6.38644 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD3, FABP3, PPARA |
6.34923 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, HTR2B, IGF1R, KDR, MET, PIM1, RELA, SMAD3, SRC, TEK |
6.3165 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CACNA1C, CNR1, CNR2, CSNK2A1, CYP1B1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MTNR1A, MTNR1B, NUAK1, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK |
6.31172 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, HSD17B3, MET, PPARA, PTGES |
6.26028 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, SRC, TEK |
6.25521 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD3, EGFR, ESR1, F2, F3, FABP4, KDR, MAP2K1, MET, MMP12, PPARA, RELA, SMAD3, TEK |
6.23354 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MAP2K1, MAP3K7, SRC, TEK, XDH |
6.23354 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CSNK2A1, DRD3, EGFR, ESR1, F2, F3, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP12, PIM1, RELA, TEK |
6.23354 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, BCL2, EGFR, ESRRB, F2, FABP3, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MAP2K1, MAP3K7, MTNR1A, SMAD3, SRC, TEK, XDH |
6.23354 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, BCL2, EGFR, ESRRB, F2, FABP3, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MAP2K1, MAP3K7, MTNR1A, SMAD3, SRC, TEK, XDH |
6.23354 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CNR1, CNR2, CYP19A1, DUSP3, EGFR, ESR1, F2, F3, FABP4, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PPARA, RELA, SMAD3, SRC, TEK, XDH |
6.22387 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PIM1, PPARA, RELA, SRC |
6.18167 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
6.13886 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GLO1, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MAP2K1, MET, MMP12, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
6.13886 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESRRB, F2, F3, FABP4, HSD17B2, HTR2A, HTR2B, HTR2C, IGF1R, INSR, MET, MMP12, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TYR |
6.06723 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, DUSP3, EGFR, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, SRC, TEK, XDH |
6.01407 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.98965 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.97198 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.91497 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.91467 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PPARA, RELA, SMAD3, SRC, TEK, XDH |
5.85165 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, MTNR1A, PPARA, RELA, SMAD3, SRC, TOP2A |
5.85165 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.77781 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
5.77781 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, HTR2B, IGF1R, KDR, PIM1, RELA, SMAD3, SRC, TEK |
5.7435 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD3, EGFR, ESR1, F2, FABP3, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
5.63295 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CYP19A1, DRD3, EGFR, F2, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, MAP2K1, MMP12, MTNR1B, PPARA, SMAD3, SRC |
5.63244 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, F2, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, NUAK1, SMAD3, SRC, TEK, XDH |
5.61261 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
5.52157 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC, TEK |
5.43095 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD3, EGFR, ESR1, MTNR1A, MTNR1B, PPARA, SRC, TOP2A |
5.34607 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, APEX1, BCL2, CNR1, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, HTR2A, HTR2B, INSR, KDR, MAP3K7, MET, PPARA, RELA, SMAD3 |
5.32505 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, F2, FLT3, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TYR |
5.20535 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA3, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, XDH |
5.18836 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.18836 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
5.1881 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
5.17834 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD3, FABP3, PPARA |
5.11317 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
5.07681 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, EGFR, INSR, MAP2K1, RELA, SMAD3, TYR |
4.9984 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, F2, FABP4, PPARA, RELA, SMAD3, TEK |
4.98947 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
4.95933 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, CNR1, CNR2, DRD3, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, RELA, SRC, TEK, TYR |
4.95509 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, EGFR, ESRRB, F2, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MAP2K1, MAP3K7, SRC, TEK, XDH |
4.87922 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, BCL2, CSNK2A1, EGFR, ESR1, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MAP2K1, MAP3K7, RELA, SMAD3, SRC, TEK, XDH |
4.87635 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.87591 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, BCL2, CNR1, CNR2, CYP19A1, DRD3, DUSP3, EGFR, ESR1, ESR2, F2, HSPA1A, IGF1R, MET, MMP12, PPARA, RELA, SMAD3, SRC, TEK, XDH |
4.87591 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA3, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, XDH |
4.85835 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD3, EGFR, HSPA1A, HTR2A, HTR2B, PPARA, RELA, SMAD3, SRC, TEK, TYR |
4.80555 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD3, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.80555 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, DUSP3, EGFR, ESRRB, F2, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, PPARA, SRC, TEK, XDH |
4.79996 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, MAP2K1, MET, MMP12, MTNR1A, PPARA, RELA, SMAD3, SRC, TOP2A |
4.79996 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, BCL2, CACNA1C, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.79465 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, F2, FABP4, HSPA1A, MAP3K7, MMP12, PPARA, RELA, SMAD3, SRC, TEK |
4.78536 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, EGFR, HTR2A, HTR2B, HTR2C, KDR, MAP2K1, SRC, TEK |
4.74563 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, CNR1, EGFR, HCAR2, HTR2B, MET, PPARA, RELA, SMAD3 |
4.72607 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, CACNA1C, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
4.69984 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, SRC |
4.67522 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CA3, CYP1B1, EGFR, HSPA1A, RELA, SRC |
4.64003 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, INSR, MAP2K1, SRC |
4.63575 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CACNA1C, CNR1, DRD3, EGFR, F2, HCAR2, HTR2B, HTR2C, MMP12, MTNR1B, SMAD3, SRC |
4.62643 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, CNR2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR2A, IGF1R, MET, MMP12, RELA, SMAD3, SRC, XDH |
4.62643 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, CNR2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR2A, IGF1R, MET, MMP12, RELA, SMAD3, SRC, XDH |
4.60767 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DUSP3, EGFR, HTR2A, HTR2B, HTR2C, KDR, MAP2K1, SRC, TEK |
4.58871 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, CNR1, CNR2, DRD3, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, RELA, SRC, TEK, TYR |
4.57372 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
4.57323 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.5654 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2 |
4.56305 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD3, EGFR, F3, INSR, MET, SRC, TEK, XDH |
4.53787 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, EGFR, F2, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MAP2K1, MAP3K7, SRC, TEK, XDH |
4.49457 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
4.48141 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.42743 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC |
4.42212 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CACNA1C, CNR1, DRD3, EGFR, HCAR2, HTR2B, HTR2C, MMP12, MTNR1B, SRC |
4.39496 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AR, AURKB, BCL2, EGFR, ESR1, ESR2, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, MET, RELA, SMAD3, SRC, TEK, XDH |
4.39496 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, RELA, SRC |
4.39496 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, RELA, SRC |
4.39496 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, RELA, SMAD3, SRC |
4.35337 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AURKB, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, NUAK1, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
4.34507 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD3, DUSP3, EGFR, ESR1, F2, F3, FLT3, FUT7, GLO1, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.3436 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, RELA, SMAD3, SRC |
4.32662 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, MAP2K1, MET, PIM1, SRC, TEK, TYR |
4.30559 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, BCL2, DUSP3, EGFR, F2, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, NUAK1, RELA, SRC, TEK, XDH |
4.30559 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, DRD3, EGFR, HTR2A |
4.28189 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, DRD3, EGFR, HTR2A |
4.28189 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, BCL2, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, SMAD3, TOP2A |
4.27793 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, CACNA1C, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
4.27793 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, F2, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, SRC, TEK, TOP2A |
4.25694 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, F2, PPARA, SMAD3, TEK |
4.24801 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.24524 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
4.234 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, DUSP3, EGFR, F2, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, SRC, TEK, XDH |
4.22032 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, F2, MMP12, PPARA, SMAD3, TEK |
4.22032 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, RELA, SRC |
4.16777 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, CACNA1C, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
4.16711 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, ESRRB, F3, HTR2A, HTR2C, INSR, KDR, MAP2K1, PIM1, RELA, SMAD3, SRC, TEK |
4.16068 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, AR, BCL2, EGFR, ESR1, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MAP2K1, MAP3K7, SMAD3, SRC, TEK, XDH |
4.1561 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, MTNR1B, NUAK1, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.15607 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F2, FABP4, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MAP2K1, MET, MMP12, PPARA, RELA, SMAD3, SRC, XDH |
4.14427 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
4.14098 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CACNA1C, CNR1, CYP19A1, DRD3, EGFR, HCAR2, HTR2A, HTR2B, HTR2C, MMP12, MTNR1B, SRC |
4.14098 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, CACNA1C, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
4.13191 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.12405 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD3, EGFR, ESR1, ESRRA, ESRRB, F2, F3, HTR2A, HTR2C, INSR, KDR, MAP2K1, NUAK1, PIM1, PPARA, RELA, SMAD3, SRC, TEK, XDH |
4.11465 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, APP, AR, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, NUAK1, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
4.1141 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, EGFR, F2, PPARA, SMAD3 |
4.1094 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
4.09869 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, CNR1, CNR2, DRD3, ESR1, F2, GPR35, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, INSR, MTNR1A, MTNR1B, SRC |
4.06174 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, NUAK1, RELA, SMAD3, SRC, TOP2A |
4.04014 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, MAP2K1, SRC |
4.01345 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD3, HSD17B3, MAOA, TYR |
3.9908 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, HTR2A, IGF1R, INSR, MAP2K1, MET, MMP12, MTNR1A, PPARA, RELA, SMAD3, SRC, TOP2A |
3.97995 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.95438 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CACNA1C, CNR1, CYP19A1, EGFR, HCAR2, HTR2A, HTR2C, MTNR1B |
3.87224 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, RELA, SRC |
3.86971 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, SRC |
3.86284 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.84776 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CACNA1C, CNR1, CYP19A1, DRD3, EGFR, HCAR2, HTR2A, HTR2B, HTR2C, MMP12, MTNR1B, SRC |
3.80962 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DRD3, EGFR, F2, HCAR2, HTR2B, INSR, MMP12, SMAD3, SRC |
3.80711 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, INSR, PPARA, RELA, SRC, TEK |
3.79317 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, DUSP3, EGFR, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, SRC, TEK |
3.79317 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, SRC |
3.77456 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CNR1, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, MAP2K1, MTNR1A, SRC, TOP2A |
3.76165 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.74555 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, RELA, SRC |
3.71121 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, BCL2, CACNA1C, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
3.68309 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, PPARA, RELA, SMAD3, SRC, TOP2A |
3.65965 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.65337 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.647 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
3.64366 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.61044 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.60712 |
[BP] GO:0007210 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.60712 |
[BP] GO:0098664 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.60712 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AXL, BCL2, CA2, CA3, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, EGFR, F2, HSPA1A, HTR2C, MAP2K1, MAP3K7, NUAK1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A |
3.60209 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, NUAK1, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
3.55804 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F3, INSR, MET, SRC, TEK |
3.55804 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, DUSP3, EGFR, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, SRC, TEK |
3.55733 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
3.54866 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, EGFR, FLT3, RELA, SRC |
3.53426 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.51835 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, RELA, SRC |
3.51372 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, APP, BCL2, CA2, CA7, CACNA1C, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
3.51352 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, BCL2, EGFR, ESR1, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, SMAD3, SRC, TEK, XDH |
3.51041 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, AR, BCL2, CACNA1C, CNR1, CSNK2A1, DRD3, EGFR, F2, HCAR2, HTR2B, MMP12, MTNR1B, SMAD3, SRC |
3.49943 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.49236 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.49236 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.49236 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.49236 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DRD3, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, PIM1, PPARA, SRC |
3.45486 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD3, EGFR, F2, HCAR2 |
3.45486 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, MAP3K7, PIM1, RELA |
3.45289 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, DRD3, FABP3, HTR2A, HTR2B, HTR2C, PPARA |
3.44544 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, CNR1, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, SMAD3, SRC, TEK |
3.43583 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, BCL2, CACNA1C, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
3.42368 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, AR, BCL2, CSNK2A1, DUSP3, EGFR, ESR1, F2, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, NUAK1, RELA, SMAD3, SRC, TEK, XDH |
3.41973 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
3.40163 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CNR1, CYP1A1, HTR2A, MAP2K1, RELA |
3.39694 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1, HSD17B3 |
3.37456 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA |
3.3705 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD3, EGFR, ESR1, ESRRA, F2, F3, INSR, KDR, MAP2K1, PIM1, RELA, SMAD3, SRC, TEK, XDH |
3.3705 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.33734 |
[BP] GO:0070201 |
None
|
ACHE, APP, BCL2, CACNA1C, CNR1, DRD3, EGFR, F2, HCAR2, HTR2B, MMP12, MTNR1B, SMAD3, SRC |
3.32001 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, F2, INSR, SMAD3, XDH |
3.30832 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, SRC |
3.29537 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, AR, BCL2, EGFR, F2, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MAP2K1, MAP3K7, SRC, TEK, XDH |
3.28219 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD3, HTR2A, HTR2B |
3.28219 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.2707 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, APEX1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GLO1, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, PIM1, PPARA, RELA, SMAD3, SRC, TOP2A |
3.22579 |
[BP] GO:0050679 |
None
|
AR, EGFR, F3, HTR2B, KDR, MMP12, TEK |
3.22032 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.20468 |
[BP] GO:0050678 |
None
|
AR, EGFR, F3, HTR2B, KDR, MMP12, SMAD3, TEK, XDH |
3.19201 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APEX1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, NUAK1, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
3.19201 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, RELA, SRC |
3.17841 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, INSR, PPARA, SRC |
3.16641 |
[BP] GO:0050708 |
None
|
ACHE, CACNA1C, CNR1, DRD3, EGFR, HCAR2, HTR2B, MMP12, MTNR1B, SRC |
3.16107 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DRD3, EGFR, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, RELA, SRC, TEK |
3.12446 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, DUSP3, ESR1, ESRRA, F2, HCAR2, HSPA1A, MAP3K7, MMP12, RELA, SMAD3, SRC |
3.12446 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, EGFR, HSPA1A, MAOA |
3.12446 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
F2, FLT3, SRC, TEK |
3.12446 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.12446 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
EGFR, ESR1, HTR2A, HTR2B |
3.12446 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA |
3.12399 |
[BP] GO:0007187 |
None
|
ADORA1, CNR1, CNR2, DRD3, HTR6, MTNR1A, MTNR1B |
3.11546 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.09266 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, DRD3, EGFR, F2, HTR2A, MMP12, PTGES, RELA, SMAD3, SRC, TYR |
3.07569 |
[BP] GO:0007610 |
None
|
APP, BCL2, CNR1, DRD3, EGFR, HTR2A, HTR2B, HTR2C, INSR, MTNR1A, PPARA |
3.04648 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
3.01626 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, FLT3, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, SRC |
3.01144 |
[BP] GO:0040008 |
regulation of growth
|
APP, AR, BCL2, CSNK2A1, DRD3, EGFR, ESR2, F2, HSPA1A, INSR, PIM1, SMAD3 |
3.01016 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, EGFR, F2, FLT3, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, SRC, TEK |
2.99586 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
EGFR, ESR1, HTR2A, HTR2B |
2.99288 |
[BP] GO:0045759 |
None
|
CNR1, CNR2, GPR35 |
2.98685 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.98114 |
[BP] GO:0051223 |
None
|
ACHE, APP, CACNA1C, CNR1, DRD3, EGFR, F2, HCAR2, HTR2B, MMP12, MTNR1B, SMAD3, SRC |
2.9288 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.92843 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.92843 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD3, MAOA, TYR |
2.92175 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, BCL2, CSNK2A1, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, SMAD3, SRC, TOP2A |
2.91641 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.91624 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, SRC |
2.90091 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.89386 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP4, FLT3, GLO1, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
2.89386 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD3, F2, PPARA, SMAD3, TEK |
2.89386 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, F2, F3, FABP4, KDR, MET, SMAD3 |
2.89386 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HCAR2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, MTNR1B, NUAK1, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
2.87168 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, RELA, SRC |
2.86456 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, BCL2, CA2, CA9, CACNA1C, CYP1B1, EGFR, ESR1, HTR2B, INSR, MET, RELA, SMAD3, SRC, TEK |
2.86088 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CYP1A1, DRD3, DUSP3, EGFR, INSR, SRC |
2.85781 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, AR, EGFR, ESR1, FLT3, IGF1R, INSR, RELA, SMAD3, SRC |
2.85379 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.84406 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, EGFR, F2, FLT3, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, SRC, TEK |
2.84399 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
CACNA1C, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
2.84069 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, RELA, TYR |
2.84069 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.82556 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, APP, AR, BCL2, CSNK2A1, DUSP3, EGFR, ESR1, F2, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, NUAK1, RELA, SMAD3, SRC, TEK, XDH |
2.82475 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, IGF1R, INSR, RELA, SRC |
2.81956 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, F2, MMP12, PTGES, RELA, SMAD3, SRC |
2.81856 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.81504 |
[BP] GO:0051254 |
None
|
APP, AR, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MAP2K1, MET, MMP12, PPARA, RELA, SMAD3, SRC, TOP2A |
2.8027 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, CNR1, DRD3, GPR35, HTR2A |
2.79583 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD3, EGFR, HCAR2, HTR2B, MMP12, SRC |
2.77669 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, DRD3, PPARA |
2.77592 |
[BP] GO:1901224 |
None
|
APP, EGFR, MAP3K7, RELA |
2.77592 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, BCL2, CYP1B1, FABP3, HSPA1A, MAP2K1, PTGES, SMAD3, XDH |
2.75709 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CYP1A1, DRD3, DUSP3, INSR |
2.75709 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, HTR2A, HTR2B, HTR2C, SRC |
2.75709 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, XDH |
2.74681 |
[BP] GO:1903798 |
None
|
EGFR, ESR1, MAP2K1 |
2.73745 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, XDH |
2.73644 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, EGFR, HTR2B |
2.70885 |
[BP] GO:0008217 |
None
|
ADORA1, AR, CNR1, DRD3, PPARA, SMAD3 |
2.67991 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FUT7, MET, PPARA, PTGES |
2.67786 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, F2, INSR, SMAD3, XDH |
2.67702 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.6573 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, MAP2K1 |
2.6573 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, F2, MMP12, PTGES, RELA, SMAD3, SRC |
2.6568 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, CACNA1C, CNR1, DRD3, F2, GPR35, HTR2A |
2.65191 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, CACNA1C, CNR1, CNR2, GPR35, KDR, SRC |
2.64706 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, BCL2, CYP1A1, DRD3, EGFR, F2, HSPA1A, HTR2A, INSR, KDR, MAP2K1, MET, MMP12, RELA, SMAD3, SRC |
2.64292 |
[BP] GO:0003018 |
None
|
ADORA1, EGFR, HTR2A, HTR2B, SRC, TEK |
2.59607 |
[BP] GO:0045595 |
regulation of cell differentiation
|
APP, AR, AXL, BCL2, CA2, CNR1, DRD3, EGFR, ESRRA, ESRRB, F2, HTR2A, HTR2C, KDR, MAP2K1, PPARA, RELA, SMAD3, XDH |
2.58176 |
[BP] GO:0031326 |
regulation of cellular biosynthetic process
|
ADORA3, APEX1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, PIM1, PPARA, RELA, SMAD3, SRC, TOP2A |
2.5699 |
[BP] GO:0051591 |
None
|
APEX1, APP, RELA, TEK, TYR |
2.55615 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, EGFR, F2, HCAR2, HTR2B, MMP12, SMAD3, SRC |
2.55615 |
[BP] GO:0045893 |
None
|
APP, AR, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, PPARA, RELA, SMAD3, SRC, TOP2A |
2.55102 |
[BP] GO:1903508 |
None
|
APP, AR, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, PPARA, RELA, SMAD3, SRC, TOP2A |
2.55102 |
[BP] GO:1902680 |
None
|
APP, AR, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, PPARA, RELA, SMAD3, SRC, TOP2A |
2.54836 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, RELA, SRC, XDH |
2.54744 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
EGFR, ESR1, HTR2A, HTR2B |
2.54744 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, PTGES |
2.54744 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES |
2.54566 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, F2, FLT3, KDR, TEK |
2.54566 |
[BP] GO:0007154 |
None
|
ADORA1, AR, AXL, BCL2, CACNA1C, CNR1, DRD3, ESR2, HTR2A, HTR2C, HTR6, MTNR1B, TEK |
2.54566 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CACNA1C, DRD3, EGFR, GPR35, HCAR2, HTR2A, HTR2C, SMAD3 |
2.54566 |
[BP] GO:0033590 |
None
|
EGFR, RELA |
2.54566 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.54566 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.54566 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.54566 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.54498 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, PTGES, RELA, SRC |
2.53508 |
[BP] GO:0045821 |
None
|
ESRRB, HTR2A, INSR |
2.53312 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CYP1B1, EGFR, ESR1, IGF1R, INSR, RELA, SRC |
2.51389 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.49858 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.46959 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.46959 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
F2, FLT3, SRC, TEK |
2.46959 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.46877 |
[BP] GO:0051197 |
None
|
ESRRB, HTR2A, INSR |
2.46877 |
[BP] GO:0051091 |
positive regulation of DNA binding transcription factor activity
|
APP, AR, ESR1, ESR2, HSPA1A, MAP3K7, RELA |
2.46642 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.46642 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, MAP2K1, TEK, TYR |
2.45724 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.4504 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, HSPA1A, RELA, SRC |
2.4504 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MAP2K1, MET, MMP12, SRC, TEK |
2.4504 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, RELA, SMAD3, SRC |
2.4504 |
[BP] GO:0098900 |
None
|
CACNA1C, CNR1, CNR2, GPR35 |
2.4479 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, EGFR, RELA, SRC, TYR |
2.44088 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES |
2.43495 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
CACNA1C, ESR1, F2, GPR35, HTR2A, HTR2B, HTR2C |
2.42232 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.42232 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGES |
2.42232 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.42232 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, EGFR, HTR2B |
2.39195 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
2.3826 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
APEX1, BCL2, CNR1, ESRRB, HSPA1A, HTR2A, HTR2B, INSR, KDR, MAP3K7, MET, PPARA |
2.37835 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
APEX1, AR, EGFR, ESR1, FLT3, INSR, RELA, SRC |
2.37283 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CNR1, CYP1A1, EGFR, ESR1, MTNR1A, SRC |
2.37225 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, BCL2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, RELA, SMAD3, SRC, XDH |
2.36761 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.36175 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD3, EGFR, INSR, MAOA, SMAD3 |
2.36175 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, HCAR2, HTR2B, MMP12, SRC |
2.36175 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1, HSD17B2, HSD17B3, PTGES |
2.36112 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MAP2K1, MMP12, SRC, TEK |
2.35522 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.34768 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP3K7, MET, SMAD3, SRC, TEK |
2.32794 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, PPARA, SMAD3, SRC, TEK |
2.32678 |
[BP] GO:0051194 |
None
|
ESRRB, HTR2A, INSR |
2.30976 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.30976 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.30976 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.30703 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.30703 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.30703 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
EGFR, ESR1, HTR2A, HTR2B |
2.30703 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, EGFR, HTR2A |
2.30703 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.30703 |
[BP] GO:0051282 |
None
|
CACNA1C, F2, HTR2A, HTR2B, HTR2C |
2.30513 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26635 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, PPARA, SMAD3, SRC, TEK |
2.26461 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, APP, AR, AURKB, BCL2, CNR1, CSNK2A1, DRD3, DUSP3, ESR1, ESR2, ESRRA, F2, FABP4, HSPA1A, HTR2B, IGF1R, MET, MMP12, PPARA, RELA, SMAD3, SRC, XDH |
2.26447 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.23853 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, F2, F3, FLT3, GPR35, IGF1R, INSR, KDR, MAP3K7, MET, RELA, SMAD3, SRC, TEK |
2.23853 |
[BP] GO:1901222 |
None
|
APP, EGFR, MAP3K7, RELA |
2.23343 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
EGFR, ESR1, HTR2A, HTR2B |
2.23343 |
[BP] GO:0023052 |
None
|
ADORA1, AR, CACNA1C, CNR1, DRD3, ESR2, HTR2A, HTR2C, HTR6, MTNR1B, TEK |
2.22338 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CNR1, DRD3, EGFR, HTR2A, INSR |
2.22338 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.22223 |
[BP] GO:0007202 |
None
|
EGFR, HTR2A, HTR2B |
2.22223 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.22223 |
[BP] GO:0045685 |
None
|
APP, DRD3, F2, RELA |
2.21204 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, HTR2A |
2.1882 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
2.1882 |
[BP] GO:0060402 |
None
|
CACNA1C, HTR2A, HTR2B, HTR2C |
2.1882 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR |
2.18434 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CNR1, CYP1A1, EGFR, RELA, TYR |
2.18061 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.17525 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, INSR, PPARA, RELA, SRC, TEK |
2.17525 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MMP12, SRC, TEK |
2.17355 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, RELA, SMAD3, SRC |
2.16936 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, EGFR, F2, HCAR2, HTR2B, MMP12, SMAD3, SRC |
2.15629 |
[BP] GO:0023014 |
signal transduction by protein phosphorylation
|
EGFR, HTR2B, INSR, KDR, MAP2K1, MAP3K7, MET, TEK |
2.15007 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, DRD3, EGFR, ESR1, ESR2, F2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, SMAD3, SRC, TEK, TOP2A |
2.14901 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
F2, FLT3, KDR, TEK |
2.14736 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.13379 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.13379 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.13379 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
2.132 |
[BP] GO:0006110 |
None
|
ESRRB, HTR2A, INSR, PPARA |
2.12974 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.12974 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.12974 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD3, EGFR, RELA, TYR |
2.1262 |
[BP] GO:0042180 |
None
|
AKR1B1, CYP19A1, GLO1, HSD17B3 |
2.08601 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, PPARA, SMAD3, SRC, TEK |
2.07516 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, F2, SMAD3, SRC |
2.06739 |
[BP] GO:0046683 |
response to organophosphorus
|
APEX1, APP, RELA, TEK, TYR |
2.06739 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.06739 |
[BP] GO:0003013 |
None
|
ADORA1, EGFR, HTR2A, HTR2B, SRC, TEK |
2.06739 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, PPARA, SRC |
2.06739 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
2.06064 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.05656 |
[BP] GO:0014059 |
None
|
CNR1, DRD3, HTR2A |
2.05656 |
[BP] GO:0070371 |
None
|
HTR2B, KDR, MAP2K1 |
2.05656 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, BCL2, DRD3, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK |
2.05582 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES |
2.04166 |
[BP] GO:0001817 |
regulation of cytokine production
|
AXL, CYP1B1, F2, HSPA1A, HTR2B, MAP3K7, MMP12, RELA, SMAD3, SRC |
2.04166 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, IGF1R, INSR, RELA, SRC |
2.04166 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
CYP1B1, HSPA1A, HTR2B, MAP3K7, MMP12, RELA, SMAD3, SRC |
2.04166 |
[BP] GO:0009411 |
response to UV
|
AURKB, BCL2, EGFR, RELA, TYR |
2.03279 |
[BP] GO:0001936 |
None
|
F3, HTR2B, KDR, TEK, XDH |
2.03279 |
[BP] GO:0007267 |
None
|
ADORA1, AR, CNR1, DRD3, ESR2, HTR2A, HTR2C, HTR6, MTNR1B, TEK |
2.00336 |
[BP] GO:0032989 |
cellular component morphogenesis
|
APP, AR, AXL, BCL2, EGFR, MET, SRC, TEK |
2.00336 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, DRD3, EGFR, ESR1, F2, F3, FLT3, GLO1, GPR35, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MTNR1A, MTNR1B, PIM1, SMAD3, SRC, TEK |
5.43095 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, CNR1, CNR2, DRD3, F3, FLT3, GPR35, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MTNR1A, MTNR1B, TEK |
4.95509 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, APP, AXL, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, DRD3, DUSP3, EGFR, F2, F3, FLT3, GPR35, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MTNR1A, MTNR1B, SRC, TEK |
4.3811 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CNR1, CNR2, DRD3, FLT3, GPR35, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MTNR1A, MTNR1B, TEK |
4.12405 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, EGFR, ESR1, F2, F3, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B2, HSD17B3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MTNR1A, MTNR1B, PIM1, PTGES, SMAD3, SRC, TEK, TYR |
4.10391 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.48913 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, DUSP3, EGFR, ESR1, F2, F3, FLT3, FUT7, GPR35, HCAR2, HSD17B2, HSD17B3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAOA, MET, MTNR1A, MTNR1B, PTGES, SRC, TEK, TYR |
3.22639 |
[CC] GO:0045121 |
membrane raft
|
APP, CNR1, EGFR, HTR2A, INSR, KDR, SRC, TEK |
2.77096 |
[CC] GO:0098857 |
membrane microdomain
|
APP, CNR1, EGFR, HTR2A, INSR, KDR, SRC, TEK |
2.75709 |
[CC] GO:0098589 |
membrane region
|
APP, CNR1, EGFR, HTR2A, INSR, KDR, SRC, TEK |
2.30703 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.25301 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B3, HSPA1A, HTR2A, HTR6, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MMP12, NUAK1, PIM1, PPARA, RELA, SHBG, SMAD3, SRC, TOP2A, TYR, XDH |
2.16936 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B3, HSPA1A, HTR2A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MMP12, NUAK1, PIM1, PPARA, RELA, SHBG, SMAD3, SRC, TOP2A, TYR, XDH |
2.11698 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA4, CA9, CACNA1C, CNR1, CNR2, CYP3A4, DRD3, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HSD17B2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAOA, MET, MTNR1A, MTNR1B, PTGES, TEK, TYR |
2.10102 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
19.1192 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP12, PIM1, PPARA, SMAD3, TYR, XDH |
13.2127 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
13.0124 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.2272 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.1869 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, CNR1, CNR2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MTNR1A, MTNR1B, PPARA, SMAD3, TEK |
10.3932 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, CNR1, CNR2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MTNR1A, MTNR1B, PPARA, TEK |
10.3409 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
9.33651 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, CNR1, CNR2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MTNR1A, MTNR1B, PPARA, TEK |
9.16433 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, CNR1, CNR2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MTNR1A, MTNR1B, PPARA, TEK |
8.86366 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, EGFR, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PPARA, SRC, TEK, TOP2A |
8.12778 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F2, F3, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PTGES, SRC, TEK, TOP2A, TYR, XDH |
7.70692 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, GLO1, HTR2A, HTR2B, HTR2C, MAP3K7, MMP12, NUAK1, PIM1, PPARA, SMAD3, TOP2A, TYR, XDH |
7.56926 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.15575 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP12, PPARA, SMAD3 |
6.73757 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.42421 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, HSD17B1, IGF1R, INSR, MTNR1A, SHBG |
6.23354 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, SHBG |
6.21056 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
6.06113 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MTNR1A, MTNR1B, TEK |
6.05613 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MTNR1A, MTNR1B, TEK |
6.05613 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.18836 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F2, GLO1, MAP3K7, MMP12, NUAK1, PIM1, PPARA, SMAD3, TOP2A, TYR, XDH |
5.13797 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
5.05154 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
5.05154 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
4.99541 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.95509 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.6398 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
4.48789 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
4.39415 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, PIM1, PPARA, RELA, SMAD3, SRC |
4.28243 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, HSD17B1, PPARA, SHBG |
4.16777 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
4.16068 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, PPARA, RELA, SMAD3, SRC |
4.11931 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.93534 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
3.74897 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.61044 |
[MF] GO:0004993 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.60712 |
[MF] GO:0099589 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.60712 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.33855 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.33855 |
[MF] GO:0043168 |
anion binding
|
AOX1, APP, AURKB, AXL, CSNK2A1, EGFR, F2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTGES, RELA, SRC, TEK, TOP2A, XDH |
3.33091 |
[MF] GO:0043176 |
None
|
HTR2A, HTR2B, HTR2C |
3.09266 |
[MF] GO:0051378 |
None
|
HTR2A, HTR2B, HTR2C |
3.09266 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, MAP2K1, MAP3K7, SMAD3 |
3.09044 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD3, HTR2A, HTR2B, HTR2C |
3.03934 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
3.01144 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
2.98685 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MTNR1A, NUAK1, PIM1, PPARA, RELA, SHBG, SMAD3, SRC, TEK, TOP2A, XDH |
2.97345 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.92843 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.92843 |
[MF] GO:0099528 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
2.91624 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AOX1, HSD17B1, HSD17B2, HSD17B3, XDH |
2.86456 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
2.83943 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, PTGES, SRC, XDH |
2.76184 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, AR, BCL2, ESR1, ESRRB, FLT3, PIM1, PPARA, RELA, SMAD3, SRC |
2.75872 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
2.59607 |
[MF] GO:0008502 |
None
|
MTNR1A, MTNR1B |
2.54566 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.54566 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.54566 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, CNR1, CNR2, DRD3, GPR35, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, MTNR1A, MTNR1B |
2.5443 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR2A, HTR2B, HTR2C |
2.46959 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.37181 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KDR, MAP3K7, MET, RELA, SMAD3, TOP2A, TYR, XDH |
2.36977 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.36977 |
[MF] GO:0030594 |
None
|
DRD3, HTR2A, HTR2B, HTR2C, HTR6 |
2.35704 |
[MF] GO:0008227 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
2.34768 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.30703 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.30703 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.30703 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.30703 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.30703 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
2.30703 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.27841 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.24833 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, RELA, SMAD3, SRC, TEK, TOP2A, XDH |
2.17355 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.12974 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.12974 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.12974 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD17B1, HSD17B2, HSD17B3 |
2.09388 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.06739 |
[MF] GO:0019899 |
enzyme binding
|
APP, AR, AURKB, BCL2, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, MET, PPARA, RELA, SMAD3, SRC, TEK, TOP2A |
2.04104 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD17B1, HSD17B2, HSD17B3 |
2.01906 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.01906 |